Abstract
Background Online triage and consultation platforms are being increasingly used by healthcare providers in the UK for patient/clinician interactions. COVID-19 accelerated the shift towards the use of these platforms to maintain healthcare provision and reduce transmission. Strict directives were introduced by the UK Government to avoid in-person contact wherever possible in March 2020.
Aim To examine patients’ experiences of online triage and consultation in UK primary care during the COVID-19 pandemic and offer considerations for their continued use.
Design This study follows the PRISMA framework and includes qualitative studies conducted in UK primary care based on the experiences of patient users of any such online platform during the period of March 2020 to April 2023. Studies were included using the PICO format. Three literature databases were searched for relevant studies: PubMed, Science Direct and EMBASE. CASP is used to assess data quality.
Results 540 studies were reviewed and reduced to 12 studies that met the inclusion criteria. Study characteristics were identified as: year of study, study population, disease types/conditions, patient response themes and the study’s data capture method. A thematic inductive approach identifies three overarching themes (Accessibility, Care delivery, System functionality) and 10 sub-themes (Affordability, IT literacy, Communication, Convenience, Care quality, Patient safety/privacy, Usability, Continuity of care, Inequality and Media influence).
Conclusion This review highlights aspects of patient satisfaction and benefit but also those most concerning for patients. This study reviews the rapid, compulsory adoption of these systems during COVID-19 with implications for their future implementation beyond the pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data derived from public domain resources
